sa.vogel

TL2 Moderator · Nijmegen

Contributes reviews on supplier material. Based in Nijmegen.

Joined 25 November 2024 · last posted 1d

92 posts, newest first. Showing up to 150.

Request: a per-category review queue Replied, post #134 · Meta › Feature requests · 27 Jul 2026 · 1 like Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
Priming a pen and whether the primed volume is wasted Replied, post #17 · Devices › Pens & autoinjectors · 22 Jul 2026 · 0 likes Picking up post #14: that is the part I would want checked first. Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #88 · Wellbeing › Sleep · 18 Jul 2026 · 10 likes On post #84 — agreed on the reasoning, with one qualification. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss,…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #44 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 32 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
Evidence quality in the secretagogue literature: an honest assessment Replied, post #2 · marked as the solution · Compounds › Secretagogues & GH axis · 12 Jul 2026 · 10 likes the opening post is right about the mechanism and I think understates the practical bit. GHRH analogues versus ghrelin mimetics are often conflated but they are…
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #21 · Clinical › Comorbidities · 12 Jul 2026 · 7 likes I read post #19 twice before replying, because I had assumed the opposite. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is…
Immortal time bias in a claims-database study — one year on Replied, post #15 · Evidence › Study critique · 9 Jul 2026 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
Submitting a sample: the process end to end Replied, post #69 · Sourcing › Independent verification · 9 Jul 2026 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Type 1 diabetes: off-label use and the evidence gap Started this topic · Clinical › Special populations · 5 Jul 2026 · 41 likes On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion. General question, not a request for advice…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #35 · Practice › Dosing & titration · 3 Jul 2026 · 11 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Athletes in weight-category sports: a different risk calculus Replied, post #8 · marked as the solution · Clinical › Special populations · 30 Jun 2026 · 10 likes post #7 answers the question as asked. The question underneath it is different. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #84 · Start Here › How to Ask · 30 Jun 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #65 · Start Here › How to Ask · 23 Jun 2026 · 16 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #22 · Analytics › Home & field testing · 23 Jun 2026 · 0 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
Tracking intake honestly when appetite is absent Replied, post #69 · Nutrition & Training › Protein & intake · 22 Jun 2026 · 2 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #24 · Pharmacology › Receptor biology · 22 Jun 2026 · 2 likes post #23 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #12 · Analytics › Impurities & related substances · 20 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #40 · Compounds › Repair & healing peptides · 11 Jun 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
The headache that turns out to be dehydration — the long version Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 9 Jun 2026 · 10 likes Worth separating two things that post #44 runs together. The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #31 · Compounds › Retatrutide · 8 Jun 2026 · 22 likes Coming back to post #29, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Follow-up: Sleep quality changes during weight loss Replied, post #35 · Wellbeing › Sleep · 1 Jun 2026 · 5 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #80 · Practice › Side effects · 13 May 2026 · 12 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #51 · Practice › Reconstitution · 13 May 2026 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. Choosing a concentration on purpose rather than by accident: starting with "I want to draw…
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Replied, post #3 · marked as the solution · Practice › Interactions · 10 May 2026 · 8 likes post #2 is right about the mechanism and I think understates the practical bit. Supplements and herbs: many have no established interaction. Some do. If you are taking…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #35 · Practice › Administration · 3 May 2026 · 27 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Batch numbers that do not match the vial label — what changed since Replied, post #4 · Sourcing › Red flags · 28 Apr 2026 · 3 likes On post #2 — agreed on the reasoning, with one qualification. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification…
Journal club: is percentage weight change the right endpoint? Replied, post #103 · Evidence › Journal club · 25 Apr 2026 · 9 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
CJC-1295 with and without DAC: what the modification does Replied, post #39 · Compounds › Secretagogues & GH axis · 22 Apr 2026 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
Coming back to: Measurement error in a self-reported exposure Replied, post #6 · Evidence › Study critique · 20 Apr 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #3 · Sourcing › Independent verification · 13 Apr 2026 · 1 like post #2 is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
Five questions in one post gets you one answer — how to split them Replied, post #51 · Start Here › How to Ask · 9 Apr 2026 · 0 likes On post #47 — agreed on the reasoning, with one qualification. The specific question in the title is more useful than you might think. A title like "a question I have"…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #66 · Analytics › Mass spectrometry · 9 Apr 2026 · 13 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Revisiting: Drawing up with one needle and injecting with another Replied, post #64 · Practice › Administration · 6 Apr 2026 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Area percent versus weight percent: the confusion that causes most arguments Replied, post #2 · Analytics › HPLC & UHPLC · 31 Mar 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Preprint servers and what screening they do Replied, post #82 · Evidence › Preprints · 9 Mar 2026 · 10 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #14 · Sourcing › Red flags · 8 Mar 2026 · 12 likes Worth separating two things that post #10 runs together. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #40 · Research Methods › Statistics · 25 Feb 2026 · 0 likes Picking up post #37: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Amylin receptor signalling and satiety — what changed since Replied, post #27 · Pharmacology › Receptor biology · 8 Feb 2026 · 22 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #16 · Pharmacology › Pharmacokinetics · 15 Jan 2026 · 8 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #78 · Compounds › Tirzepatide · 11 Dec 2025 · 17 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
What pooling buys you and what it destroys Replied, post #83 · Evidence › Meta-analyses · 4 Dec 2025 · 13 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
A parcel stationary at a customs facility for nine days Replied, post #9 · Sourcing › Logistics · 3 Dec 2025 · 10 likes This follows post #6 rather than contradicting it. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #95 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Picking up post #92: that is the part I would want checked first. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #56 · Practice › Interactions · 24 Nov 2025 · 29 likes Picking up post #53: that is the part I would want checked first. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which…
[2026 update] What steady state means for the decision to escalate Replied, post #41 · Practice › Dosing & titration · 9 Nov 2025 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Follow-up: Why appetite effects are mostly central Replied, post #83 · Pharmacology › Receptor biology · 1 Nov 2025 · 16 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
The anatomy of a question that gets answered within an hour — the long version Replied, post #25 · Start Here › How to Ask · 25 Oct 2025 · 23 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
EMA product information as a primary source Replied, post #2 · Regional › European Union · 24 Oct 2025 · 5 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #100 · Lounge › Off topic · 16 Oct 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Pricing far outside the range, in either direction Replied, post #4 · Sourcing › Red flags · 26 Sep 2025 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #6 · Compounds › Tirzepatide · 22 Sep 2025 · 5 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Reading a supplier's product description as a marketing document Replied, post #70 · Compounds › Other compounds · 13 Sep 2025 · 13 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #53 · Practice › Reconstitution · 8 Sep 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #16 · Devices › Pens & autoinjectors · 26 Aug 2025 · 1 like post #15 is right about the mechanism and I think understates the practical bit. Off-label dosing with a pen: if you want to deliver a dose different from the pen's…
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #30 · Analytics › Mass spectrometry · 22 Aug 2025 · 21 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
A request that was declined, and the reasoning — a second dataset Replied, post #88 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
A request that was declined, and the reasoning — a second dataset Replied, post #63 · Documentation › Wiki requests · 12 Aug 2025 · 10 likes Coming back to post #61, because the follow-up matters more than the original answer. Correction requests: if you spot an error in a maintained page, note it here with…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #149 · Devices › Cold chain · 24 Jul 2025 · 9 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #139 · Compounds › Tirzepatide · 17 Jul 2025 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Regional warehouse stock versus direct despatch Replied, post #6 · Sourcing › Logistics · 14 Jul 2025 · 15 likes On post #2 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Sodium, potassium and magnesium when intake drops Replied, post #34 · Nutrition & Training › Hydration & electrolytes · 28 Jun 2025 · 10 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
Vagal afferents and the gut-brain pathway Replied, post #8 · Pharmacology › Receptor biology · 19 Jun 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #31 · Evidence › Trials · 13 Jun 2025 · 4 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
[2026 update] An appeal that failed, and what I would do differently Replied, post #54 · Access › Insurance & coverage · 10 Jun 2025 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #99 · Clinical › Comorbidities · 30 May 2025 · 17 likes Worth separating two things that post #95 runs together. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #8 · Evidence › Journal club · 18 May 2025 · 1 like post #7 is right about the mechanism and I think understates the practical bit. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
Anxiety in the first weeks: drug, situation, or both Replied, post #89 · Wellbeing › Mental health · 16 May 2025 · 0 likes This follows post #86 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 12 May 2025 · 10 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Counter-ion content and its effect on measured mass Replied, post #33 · Analytics › Mass spectrometry · 7 May 2025 · 1 like Resolution: "high resolution" commonly means
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #10 · Clinical › Bloodwork · 23 Apr 2025 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 4 Apr 2025 · 27 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #7 · marked as the solution · Start Here › Welcome · 23 Mar 2025 · 18 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #22 · Compounds › Secretagogues & GH axis · 10 Mar 2025 · 3 likes Coming back to post #20, because the follow-up matters more than the original answer. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone…
Ipamorelin selectivity claims and where they came from Replied, post #18 · Compounds › Secretagogues & GH axis · 6 Mar 2025 · 2 likes Worth separating two things that post #14 runs together. Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 24 Feb 2025 · 16 likes post #70 is right about the mechanism and I think understates the practical bit. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
Consistent declarations and why they matter more than clever ones Replied, post #44 · Sourcing › Logistics · 17 Feb 2025 · 15 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #90 · Evidence › Meta-analyses · 10 Feb 2025 · 5 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
Reading an MS report that only gives you a single number Replied, post #6 · Analytics › Mass spectrometry · 6 Feb 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #46 · Devices › Cold chain · 3 Feb 2025 · 1 like post #45 is right about the mechanism and I think understates the practical bit. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque…
Reading a supplementary appendix and finding the interesting part Replied, post #58 · Evidence › Trials · 2 Jan 2025 · 21 likes On post #54 — agreed on the reasoning, with one qualification. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses…
Coming back to: When to suspect the method rather than the sample Replied, post #59 · Analytics › Method validation · 11 Dec 2024 · 6 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #42 · Access › Insurance & coverage · 26 Nov 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #37 · Compounds › Tirzepatide · 15 Nov 2024 · 31 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
Follow-up: What this community means by "a source", in practical terms Replied, post #12 · Start Here › Welcome · 6 Nov 2024 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #10 · Compounds › Other compounds · 2 Nov 2024 · 4 likes This follows post #7 rather than contradicting it. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #85 · Compounds › Other compounds · 31 Oct 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #66 · Compounds › Other compounds · 22 Oct 2024 · 13 likes Coming back to post #64, because the follow-up matters more than the original answer. Research-use-only status is a legal classification, not a safety classification.…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #130 · Clinical › Bloodwork · 21 Oct 2024 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #14 · Practice › Administration · 7 Sep 2024 · 26 likes I read post #12 twice before replying, because I had assumed the opposite. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles…
Guidelines revision: what changed and why Replied, post #26 · Meta › Announcements · 25 Jul 2024 · 9 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #36 · Compounds › Retatrutide · 18 Jul 2024 · 22 likes On post #32 — agreed on the reasoning, with one qualification. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a…
Where the four-week escalation interval comes from, and what it is not Replied, post #19 · Practice › Dosing & titration · 12 Jun 2024 · 0 likes On post #15 — agreed on the reasoning, with one qualification. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…